BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31970698)

  • 1. Combination of Human Mesenchymal Stem Cells and Repetitive Transcranial Magnetic Stimulation Enhances Neurological Recovery of 6-Hydroxydopamine Model of Parkinsonian's Disease.
    Lee JY; Kim HS; Kim SH; Kim HS; Cho BP
    Tissue Eng Regen Med; 2020 Feb; 17(1):67-80. PubMed ID: 31970698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of repetitive transcranial magnetic stimulation in an animal model of Parkinson's disease.
    Lee JY; Kim SH; Ko AR; Lee JS; Yu JH; Seo JH; Cho BP; Cho SR
    Brain Res; 2013 Nov; 1537():290-302. PubMed ID: 23998987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Repetitive Transcranial Magnetic Stimulation Exerts Neuroprotective Effects and Improves Motor Functions in Hemiparkinsonian Rats.
    Hsieh TH; He XK; Liu HH; Chen JJ; Peng CW; Liu HL; Rotenberg A; Chen KT; Chang MY; Chiang YH; Chang PK; Kuo CW
    Neural Plast; 2021; 2021():1763533. PubMed ID: 34987572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of repetitive transcranial magnetic stimulation on a model rat of Parkinson's disease.
    Yang X; Song L; Liu Z
    Neuroreport; 2010 Mar; 21(4):268-72. PubMed ID: 20087233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranigral transplantation of epigenetically induced BDNF-secreting human mesenchymal stem cells: implications for cell-based therapies in Parkinson's disease.
    Somoza R; Juri C; Baes M; Wyneken U; Rubio FJ
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1530-40. PubMed ID: 20542127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repetitive transcranial magnetic stimulation (rTMS) improves behavioral and biochemical deficits in levodopa-induced dyskinetic rats model.
    Ba M; Kong M; Guan L; Yi M; Zhang H
    Oncotarget; 2016 Sep; 7(37):58802-58812. PubMed ID: 27613848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha.
    Wang F; Yasuhara T; Shingo T; Kameda M; Tajiri N; Yuan WJ; Kondo A; Kadota T; Baba T; Tayra JT; Kikuchi Y; Miyoshi Y; Date I
    BMC Neurosci; 2010 Apr; 11():52. PubMed ID: 20420688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson's disease.
    Migliore MM; Ortiz R; Dye S; Campbell RB; Amiji MM; Waszczak BL
    Neuroscience; 2014 Aug; 274():11-23. PubMed ID: 24845869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson's Disease.
    Teixeira FG; Vilaça-Faria H; Domingues AV; Campos J; Salgado AJ
    Cells; 2020 Jan; 9(2):. PubMed ID: 32012897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat.
    Blandini F; Cova L; Armentero MT; Zennaro E; Levandis G; Bossolasco P; Calzarossa C; Mellone M; Giuseppe B; Deliliers GL; Polli E; Nappi G; Silani V
    Cell Transplant; 2010; 19(2):203-17. PubMed ID: 19906332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Dopaminergic Neurons in Substantia Nigra are Required for Transcranial Magnetic Stimulation-Induced Motor Plasticity.
    Hsieh TH; Huang YZ; Rotenberg A; Pascual-Leone A; Chiang YH; Wang JY; Chen JJ
    Cereb Cortex; 2015 Jul; 25(7):1806-14. PubMed ID: 24451657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells augment neurogenesis in the subventricular zone and enhance differentiation of neural precursor cells into dopaminergic neurons in the substantia nigra of a parkinsonian model.
    Park HJ; Shin JY; Lee BR; Kim HO; Lee PH
    Cell Transplant; 2012; 21(8):1629-40. PubMed ID: 22546197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repetitive transcranial magnetic stimulation alleviates glial activation through suppressing HMGB1/TLR4 pathway in a rat model of Parkinson's disease.
    Han C; Zhang X; Dou K; Yao W; Yao M; Wan Q; Xie A
    Mol Biol Rep; 2023 Aug; 50(8):6481-6492. PubMed ID: 37328582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical exercise and human adipose-derived mesenchymal stem cells ameliorate motor disturbances in a male rat model of Parkinson's disease.
    Cucarián JD; Berrío JP; Rodrigues C; Zancan M; Wink MR; de Oliveira A
    J Neurosci Res; 2019 Sep; 97(9):1095-1109. PubMed ID: 31119788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced neurotrophic distribution, cell signaling and neuroprotection following substantia nigral versus striatal delivery of AAV2-NRTN (CERE-120).
    Herzog CD; Brown L; Kruegel BR; Wilson A; Tansey MG; Gage FH; Johnson EM; Bartus RT
    Neurobiol Dis; 2013 Oct; 58():38-48. PubMed ID: 23631873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Clec7a as the therapeutic target of rTMS in alleviating Parkinson's disease: targeting neuroinflammation.
    Chen XY; Feng SN; Bao Y; Zhou YX; Ba F
    Biochim Biophys Acta Mol Basis Dis; 2023 Dec; 1869(8):166814. PubMed ID: 37495085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes isolated during dopaminergic neuron differentiation suppressed neuronal inflammation in a rodent model of Parkinson's disease.
    Li Y; Li Z; Gu J; Xu X; Chen H; Gui Y
    Neurosci Lett; 2022 Feb; 771():136414. PubMed ID: 34954117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of engineered conserved dopamine neurotrophic factor-expressing bone marrow stromal cells on dopaminergic neurons following 6-OHDA administrations.
    Mei J; Niu C
    Mol Med Rep; 2015 Feb; 11(2):1207-13. PubMed ID: 25373844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Puerarin promoted proliferation and differentiation of dopamine-producing cells in Parkinson's animal models.
    Shiying L; Xinhui Q; Guanghua J; Feng N; Feng L; Shumei C; Fan H
    Biomed Pharmacother; 2018 Oct; 106():1236-1242. PubMed ID: 30119192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentraxin 3 secreted by human adipose-derived stem cells promotes dopaminergic neuron repair in Parkinson's disease via the inhibition of apoptosis.
    Lian C; Huang Q; Zhong X; He Z; Liu B; Zeng H; Xu N; Yang Z; Liao C; Fu Z; Guo H
    FASEB J; 2021 Jul; 35(7):e21748. PubMed ID: 34152016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.